Evidence map›Paper›PMID 33972701›Full record

ArticleBone marrow transplantation2021

Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.

Alexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, Angel Garced, Krishna C Devarasetty, Megan Wall, Supriya M Menezes, Sveti Ugarte, Filip Pirsl, Sencer Goklemez and 6 more

Abstract readPublished Erratum
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Alexandra A PietraszkiewiczNational Eye Institute, National Institutes of Health, Bethesda, MD, USA. olapietra@gmail.com.ORCID http://orcid.org/0000-0002-9982-6261
Debbie PayneNational Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Maria AbrahamThe Emmes Company, LLC, Rockville, MD, USA.
Angel GarcedNational Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Krishna C DevarasettyThe Emmes Company, LLC, Rockville, MD, USA.
Megan WallThe Emmes Company, LLC, Rockville, MD, USA.
Supriya M MenezesThe Emmes Company, LLC, Rockville, MD, USA.
Sveti UgarteAllergan, Inc., Irvine, CA, USA.
Filip PirslNational Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-7919-0211
Sencer GoklemezNational Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Frederick L FerrisNational Eye Institute, National Institutes of Health, Bethesda, MD, USA.
John BarrettNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Minoo BattiwallaNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Richard W ChildsNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Steven Z PavleticNational Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Rachel J BishopNational Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Funding

Allogeneic Immunotherapy for cancer and nonmalignant hematological disordersZIAHL002345 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CHILDS, RICHARD · 2009 to 2025
$53.3M
A Phase II Study Evaluating Fostamatinib for Hospitalized Adults with COVID-19.ZIAHL006250 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CHILDS, RICHARD · 2020 to 2023
$2.4M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33972701
PMCPMC8414782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.